tiprankstipranks
Cue Biopharma Reports Increased Revenue Amid Ongoing Losses
PremiumCompany AnnouncementsCue Biopharma Reports Increased Revenue Amid Ongoing Losses
5M ago
Cue Biopharma reports Q3 EPS (17c), consensus (19c)
Premium
The Fly
Cue Biopharma reports Q3 EPS (17c), consensus (19c)
5M ago
Cue names Daniel Baker interim CDO, CSO Amish Suri to transition to advisor role
Premium
The Fly
Cue names Daniel Baker interim CDO, CSO Amish Suri to transition to advisor role
5M ago
Cue Biopharma announces pricing of $12M public offering
PremiumThe FlyCue Biopharma announces pricing of $12M public offering
6M ago
Cue Biopharma announces common stock, warrant offering, no amount given
Premium
The Fly
Cue Biopharma announces common stock, warrant offering, no amount given
6M ago
Cue Biopharma appoints Lucinda Warren as CBO
Premium
The Fly
Cue Biopharma appoints Lucinda Warren as CBO
7M ago
Cue Biopharma price target lowered to $3 from $8 at Piper Sandler
PremiumThe FlyCue Biopharma price target lowered to $3 from $8 at Piper Sandler
8M ago
Cue Biopharma price target lowered to $2 from $15 at JMP Securities
Premium
The Fly
Cue Biopharma price target lowered to $2 from $15 at JMP Securities
8M ago
Cue Biopharma Refocuses on Autoimmune Programs, Restructures Operations
Premium
Company Announcements
Cue Biopharma Refocuses on Autoimmune Programs, Restructures Operations
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100